APA

Schmieder R. E., Potthoff S. A., Bramlage P., Baumgart P., Mahfoud F., Buhck H., Ouarrak T., Ehmen M., Senges J. & Gitt A. K. (20161213). Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. : Journal of clinical hypertension (Greenwich, Conn.).

Chicago

Schmieder Roland E, Potthoff Sebastian A, Bramlage Peter, Baumgart Peter, Mahfoud Felix, Buhck Hartmut, Ouarrak Taoufik, Ehmen Martina, Senges Jochen and Gitt Anselm K. 20161213. Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. : Journal of clinical hypertension (Greenwich, Conn.).

Harvard

Schmieder R. E., Potthoff S. A., Bramlage P., Baumgart P., Mahfoud F., Buhck H., Ouarrak T., Ehmen M., Senges J. and Gitt A. K. (20161213). Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. : Journal of clinical hypertension (Greenwich, Conn.).

MLA

Schmieder Roland E, Potthoff Sebastian A, Bramlage Peter, Baumgart Peter, Mahfoud Felix, Buhck Hartmut, Ouarrak Taoufik, Ehmen Martina, Senges Jochen and Gitt Anselm K. Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. : Journal of clinical hypertension (Greenwich, Conn.). 20161213.